Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

SEC Casting Wide Net in Galena Investigation
TheStreet.com
Wednesday, May 14, 2014 - 4:36pm
tags:
SEC, Galena Biopharma, Lion Biotechnologies
UK lawmaker stirs political row with Pfizer "rapist" comments
Yahoo/Reuters
Wednesday, May 14, 2014 - 4:21pm
tags:
UK, Pfizer, AstraZeneca, M&A
Senators urge U.S. anti-trust review of Pfizer-AstraZeneca plan
Reuters
Wednesday, May 14, 2014 - 4:18pm
tags:
Pfizer, AstraZeneca, antitrust, M&A
Actavis says Forest CEO Brent Saunders to head company after acquisition
First Word Pharma
Wednesday, May 14, 2014 - 11:19am
tags:
Brent Saunders, Forest Labs, Actavis, M&A
Blockbuster sales of Insys painkiller raise suspicions of off-label marketing
Fierce Pharma
Wednesday, May 14, 2014 - 11:16am
tags:
Subsys, painkillers, off-label, Insys
[audio]Gabelli’s Jonas Says Pfizer Deal Will Get Done
Bloomberg
Wednesday, May 14, 2014 - 11:15am
tags:
Pfizer, M&A, AstraZeneca
Swedish unions urge government to oppose Pfizer bid for Astra
Yahoo/Reuters
Wednesday, May 14, 2014 - 10:54am
tags:
Sweden, Pfizer, AstraZeneca, M&A
Bristol, Celldex Collaborating on Cancer Immunotherapy Study
TheStreet.com
Wednesday, May 14, 2014 - 9:10am
tags:
cancer immunotherapy, Celldex, Bristol-Myers Squibb
GSK says China bribery charges 'deeply concerning'
Reuters
Wednesday, May 14, 2014 - 8:55am
tags:
GSK, China, bribery
Pfizer CEO Read Says AstraZeneca Bid Won’t Harm Patients
Bloomberg
Wednesday, May 14, 2014 - 8:54am
tags:
Ian Read, Pfizer, Pharma CEOs, AstraZeneca, M&A
Antidepressant Use Has Exploded Since 1988
Yahoo/Business Insider
Wednesday, May 14, 2014 - 8:36am
tags:
antidepressants, depression
Johnson & Johnson: Now What?
Seeking Alpha
Wednesday, May 14, 2014 - 8:22am
tags:
JNJ
[video]ASCO Abstracts: Bristol-Myers Squibb's and Merck's Immuno-Oncology Drugs
Motley Fool
Wednesday, May 14, 2014 - 8:22am
tags:
ASCO, Bristol-Myers Squibb, Merck, immuno-oncology
Cambridge Sees Pfizer Pursuit as Disrupting Science Hub
Bloomberg
Wednesday, May 14, 2014 - 8:20am
tags:
Pfizer, Cambridge, R&D, M&A, AstraZeneca
Trials Are Expected In Japan And China, But Arena's Belviq International Sales Will Have To Wait
Seeking Alpha
Wednesday, May 14, 2014 - 8:20am
tags:
Japan, China, Arena Pharmaceuticals, Belviq, obesity, Eisai
AstraZeneca and Incyte to study cancer drugs together
Yahoo/Reuters
Wednesday, May 14, 2014 - 8:18am
tags:
AstraZeneca, Incyte, cancer, R&D
Isis Pharma's diabetes drug succeeds in mid-stage study
Street Insider
Wednesday, May 14, 2014 - 8:17am
tags:
Isis Pharmaceuticals, ISIS-GCGRRx, diabetes
J&J taps British science quietly where Pfizer storms in
Yahoo/Reuters
Wednesday, May 14, 2014 - 8:14am
tags:
JNJ, Pfizer, AstraZeneca, UK
GlaxoSmithKline's blockbuster dreams dashed as darapladib goes 0-for-2 in PhIII
Fierce Biotech
Tuesday, May 13, 2014 - 10:25pm
tags:
GSK, darapladib
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
The Fly on the Wall
Tuesday, May 13, 2014 - 10:21pm
tags:
Amgen, evolocumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.